DLC1 and breast cancer: DLC1 was reported to suppress parathyroid hormone-like hormone (PTHLH) transcription and secretion through Rho-TGF-β crosstalk, leading to attenuate osteoclast maturation and reduce breast cancer bone metastasis (7).